⌘K

Login Start Free

Immune Therapeutics, Inc.|5Mar 30, 5:03 PM ET

DAILEY ROBERT JACKMAN 5

5 · Immune Therapeutics, Inc. · Filed Mar 30, 2018

Insider Transaction Report

Form 5

Period: 2017-12-31

Immune Therapeutics, Inc.IMUN

DAILEY ROBERT JACKMAN

Other

Transactions

Purchase
Common stock
2016-11-29$0.06/sh+1,000$63→ 20,800,359 total
Purchase
Common stock
2016-12-14$0.07/sh+1,250$86→ 20,800,359 total
Purchase
Common stock
2016-12-14$0.07/sh+1,550$115→ 20,800,359 total
Purchase
Common stock
2016-11-29$0.16/sh+1,000$161→ 20,800,359 total
Purchase
Common stock
2016-11-28$0.06/sh+1,000$62→ 20,800,359 total
Purchase
Common stock
2016-11-29$0.16/sh+1,000$163→ 20,800,359 total
Purchase
Common stock
2016-11-29$0.06/sh+1,000$63→ 20,800,359 total
Purchase
Common stock
2016-12-06$0.06/sh+1,000$59→ 20,800,359 total
Purchase
Common stock
2016-12-08$0.07/sh+500$37→ 20,800,359 total
Purchase
Common stock
2016-11-29$0.06/sh+1,000$63→ 20,800,359 total
Purchase
Common stock
2016-11-29$0.06/sh+1,000$61→ 20,800,359 total
Purchase
Common stock
2016-12-02$0.06/sh+1,000$63→ 20,800,359 total

Documents

1 file

5
primary_doc.xmlPrimary
PRIMARY DOCUMENT